Literature DB >> 12918769

High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.

F Davatchi1, F Shahram, H Chams, A R Jamshidi, A Nadji, C Chams, M Akbarian, F Gharibdoost.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12918769     DOI： 10.1007/0-306-48382-3_118

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

Review 1.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 2.  Orbital Vasculitides-Differential Diagnosis.

Authors:  Gabriela M Espinoza; Jessica L Liu
Journal:  Curr Rheumatol Rep       Date:  2019-09-05       Impact factor: 4.592

3.  New Evidence-Based Treatment Approach in Behçet's Disease.

Authors:  Erkan Alpsoy
Journal:  Patholog Res Int       Date:  2011-10-05

Review 4.  Biological treatments in Behçet's disease: beyond anti-TNF therapy.

Authors:  Francesco Caso; Luisa Costa; Donato Rigante; Orso Maria Lucherini; Paolo Caso; Vittoria Bascherini; Bruno Frediani; Rolando Cimaz; Edoardo Marrani; Laura Nieves-Martín; Mariangela Atteno; Carmela G L Raffaele; Giusyda Tarantino; Mauro Galeazzi; Leonardo Punzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2014-06-30       Impact factor: 4.711

5.  Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.

Authors:  Fouad R Zakka; Peter Y Chang; Gian P Giuliari; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2009-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.